Australia Veterinary Cro And Cdmo Market Size & Outlook
Australia veterinary cro and cdmo market, 2018-2030 (US$Ms)
Related Markets
Australia veterinary cro and cdmo market highlights
- The Australia veterinary cro and cdmo market generated a revenue of USD 97.5 millions in 2022 and is expected to reach USD 210.1 millions by 2030.
- The Australia market is expected to grow at a CAGR of 10.1% from 2023 to 2030.
- In terms of segment, livestock animals was the largest revenue generating animal type in 2022.
- Companion Animals is the most lucrative animal type segment registering the fastest growth during the forecast period.
Veterinary cro and cdmo market data book summary
| Market revenue in 2022 | USD 97.5 millions |
| Market revenue in 2030 | USD 210.1 millions |
| Growth rate | 10.1% (CAGR from 2022 to 2030) |
| Largest segment | Livestock animals |
| Fastest growing segment | Companion Animals |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD millions |
| Market segmentation | Companion Animals, Livestock Animals |
| Key market players worldwide | Labcorp Holdings Inc, Charles River Laboratories International Inc, Hannover Rueck SE, Inotiv Inc, IDEXX Laboratories Inc, Zoetis Inc Class A, Swedencare AB, Clinvet, Oncovet Clinical Research, knoell, Vetspin |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global veterinary cro and cdmo market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China veterinary cro and cdmo market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,007.0 millions by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary CRO And CDMO Market Scope
Veterinary CRO And CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia veterinary cro and cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary cro and cdmo market will help companies and investors design strategic landscapes.
Livestock animals was the largest segment with a revenue share of 59.69% in 2022. Horizon Databook has segmented the Australia veterinary cro and cdmo market based on companion animals, livestock animals covering the revenue growth of each sub-segment from 2018 to 2030.
Strong government support, increased investments for technological advancements, and high adoption of pets are some of the major market drivers. Novotech Pty Ltd., Pfizer Animal Health Australia Pty Ltd. (now part of Zoetis), Cytopoint Biotech Pty Ltd., ClinTrials Pty Ltd., and QVet Innovations Pty Ltd. are some of the major CROs and CDMOs in the country.
Reasons to subscribe to Australia veterinary cro and cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia veterinary cro and cdmo market databook
-
Our clientele includes a mix of veterinary cro and cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia veterinary cro and cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Australia veterinary cro and cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia veterinary cro and cdmo market size, by animal type, 2018-2030 (US$Ms)
Australia Veterinary CRO And CDMO Market Outlook Share, 2022 & 2030 (US$Ms)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
